Clinical Trials Logo

Filter by:
NCT ID: NCT04035629 Not yet recruiting - Clinical trials for Bronchopulmonary Dysplasia

129Xe MRI in Pediatric Population With BPD

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional

Hyperpolarized (HP) gas magnetic resonance imaging (MRI) of the lungs offers additional information that cannot be obtained with CT scan, the current gold standard for imaging this disorder. As a nonionizing technique, MRI is an ideal modality for pulmonary imaging; in particular in the infant and pediatric population. Nevertheless, due to the low proton density of the lung parenchyma (only ~20% that of solid tissues), numerous air-tissue interfaces that lead to rapid signal decay, and cardiac and respiratory sources of motion that further degrade image quality , MRI has played a limited role in the evaluation of lung pathologies. In this setting, HP gas (using 129Xe) MRI may play a role in helping determine the regional distribution of alveolar sizes, partial pressure of oxygen, alveolar wall thickness, and gas transport efficiency of the microvasculature within the lungs of infants with a diagnosis of bronchopulmonary dysplasia (BPD).

NCT ID: NCT04092348 Not yet recruiting - Clinical trials for Acute Lymphoblastic Leukemia

FoxO3a and PU.1 in Acute Lymphoblastic Leukemia

Start date: August 1, 2023
Phase:
Study type: Observational

Acute Lymphoblastic Leukemia (ALL) is one of the four major types of leukemia which is common in both children and adolescents; however, it is the most common pediatric malignancy diagnosed in children younger than 20 years .The disease pathogenesis results from blockade at any stages of normal lymphoid differentiation with uncontrolled proliferation of lymphoid cells. According to the World Health Organization (WHO) definition, ALL is categorized in B-Lymphoblastic Leukemia (B-ALL) And T-Lymphoblastic Leukemia (T-ALL), originated from B- and T-Lineage lymphoid precursor cells, respectively.

NCT ID: NCT04457882 Not yet recruiting - Prostate Cancer Clinical Trials

Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

This is a randomized controlled and non-inferiority trial in comparison of intraperitoneal laparoscopic radical prostatectomy without drainage tube between intraperitoneal laparoscopic radical prostatectomy with drainage tube in the safety in men with a localized prostate cancer.

NCT ID: NCT04517279 Not yet recruiting - Psychotic Disorders Clinical Trials

Peer Approaches to Substances in Early Psychosis Programs: A Pilot Study of a Peer-Led Intervention

PAS-EPP
Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to pilot a peer-provided, manualized intervention to increase the proportion of young people with first episode psychosis who reduce or stop substance use and improve psychiatric and functional outcomes. Coordinated specialty care teams will be randomly assigned to implement the intervention, Peer Approaches to Substances in Early Psychosis Programs (PAS-EPP), or usual care. The pilot study aims to: (a) determine if peer providers can implement PAS-EPP with adequate fidelity; (b) determine if youth and young adults engage in the intervention with peer providers and find it acceptable; (c) estimate the rates of drop-out for each of the two study arms; (d) estimate both between-participant (within-provider team) and between-team variability on key outcome measures; and (e) identify any changes needed to the intervention approach, manual, or training materials. The pilot study will set the stage for a future comparative cluster randomized trial of the intervention;

NCT ID: NCT04909203 Not yet recruiting - Clinical trials for Suicide and Self-harm

iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

This study is a 16-week intent-to-treat randomized controlled trial (RCT) with 120 suicidal juvenile justice (JJ)-involved transition-age (TA) youth (age 15-21 years) and a primary caregiver (dyads). Dyads will be randomly assigned to iKinnect2.0 (n=60 dyads) or Life360 (control app) plus an electronic suicide resources brochure (n=60 dyads). This design will test iKinnect2.0's new features for suicide prevention against TA youth awareness of and access to high-quality suicide prevention resources, while simultaneously testing features relating to conduct problems and parent management against parents knowing the TA youth's whereabouts in real-time and controlling for dyad member engagement in technology (Life360). Participants will be assessed at baseline, 4, 8 and 16 weeks. Primary youth-reported outcomes relating to suicide risk include: Suicidal behaviors (ideation, planning, attempts), non-suicidal self-injurious behaviors, self-efficacy in coping with distress, and use of imminent distress coping strategies (behavioral skills, use of crisis stabilization plan). Youth will also report on their criminal behavior. Primary caregiver-reported outcome variables relating to youth suicide include: Self-efficacy in applying family-based suicide-prevention strategies and reported use of those strategies; caregivers will also report on their own functioning (efficacy/confidence in parenting skills, life stress), TA youth functioning (internalizing and externalizing symptoms), parental management behaviors (expectation clarity, parental monitoring, discipline effectiveness/consistency, use of rewards), and parent-youth relationship quality (communication, conflict, support). App satisfaction and use of technology outcomes (i.e., degree of app usage, features used) will be examined and reported descriptively.

NCT ID: NCT04958694 Not yet recruiting - Adolescent Behavior Clinical Trials

CEDARS Intervention: A Coping, Emotional Development, & Stress Reduction Intervention

CEDARS
Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Using an adapted stress-reduction intervention called the CEDARS, we will pilot the intervention in adolescents (N=50) to determine the feasibility and acceptability of CEDARS implementation and to investigate adolescent stress reduction. As an exploratory aim, we will explore the influence of the CEDARS on CMH-related behaviors and CMH. We expect that those adolescents who undergo the intervention will have the greatest improvement in mental health symptoms than their waitlisted counterparts. Our secondary hypothesis is that those who report more adversity will also report greater improvement in mental health symptoms than their peers.

NCT ID: NCT04966416 Not yet recruiting - Systemic Sclerosis Clinical Trials

Calcinosis Reduction by Pyrophosphate in SSC

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Calcinosis, i.e. crystal-like nodules are troublesome complication of systemic sclerosis, an autoimmune disease. Pyrophosphate inhibits its formation is laborytory. We would like to test if orally administered pyrophosphate prevents calcinosis formation.

NCT ID: NCT05014243 Not yet recruiting - Inflammation Clinical Trials

Targeted Metabolomics to Decipher Dietary Contributions to Pediatric Inflammatory Bowel Disease (IBD) - Main Study

TAMED IBD
Start date: August 1, 2023
Phase:
Study type: Observational

The overall goal of the study is to investigate the dietary differences between children with well-controlled inflammatory bowel disease (IBD) and those with active disease by using targeted food metabolomics. The utilization of the application of targeted metabolomics allows for the investigation of specific components of foods and their effects in IBD and inflammation, which may inform future dietary recommendations for IBD patients.

NCT ID: NCT05194332 Not yet recruiting - Clinical trials for Depressive Disorder, Major

Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive Function

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the low-intensity focused ultrasound pulsation (LIFUP) neuromodulation on emotion processing in healthy individuals, and to assess the overall safety of the LIFUP to stimulate or inhibit brain activity in healthy volunteers.

NCT ID: NCT05461404 Not yet recruiting - Clinical trials for Very Low Birth Weight Infant

Emollient Therapy for Premature Infants in Zimbabwe

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of topical emollient treatments in improving neonatal growth and mortality rates.